Zurcher Kantonalbank Zurich Cantonalbank Purchases 658 Shares of Clorox Co (NYSE:CLX)

Zurcher Kantonalbank Zurich Cantonalbank grew its position in Clorox Co (NYSE:CLX) by 2.2% during the third quarter, HoldingsChannel.com reports. The fund owned 30,196 shares of the company’s stock after acquiring an additional 658 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Clorox were worth $4,586,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in CLX. Asahi Life Asset Management CO. LTD. bought a new position in shares of Clorox during the 2nd quarter valued at approximately $340,000. Cambridge Investment Research Advisors Inc. increased its position in shares of Clorox by 3.2% during the 2nd quarter. Cambridge Investment Research Advisors Inc. now owns 27,406 shares of the company’s stock valued at $4,196,000 after purchasing an additional 858 shares during the last quarter. Ontario Teachers Pension Plan Board increased its position in shares of Clorox by 209.0% during the 2nd quarter. Ontario Teachers Pension Plan Board now owns 37,846 shares of the company’s stock valued at $5,795,000 after purchasing an additional 25,599 shares during the last quarter. CWM LLC increased its position in shares of Clorox by 75.6% during the 2nd quarter. CWM LLC now owns 92,127 shares of the company’s stock valued at $14,106,000 after purchasing an additional 39,668 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. increased its position in shares of Clorox by 4.2% during the 2nd quarter. Charles Schwab Investment Management Inc. now owns 969,843 shares of the company’s stock valued at $148,493,000 after purchasing an additional 39,390 shares during the last quarter. 78.45% of the stock is currently owned by institutional investors and hedge funds.

In other Clorox news, SVP Michael R. Costello sold 3,225 shares of the company’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $161.34, for a total value of $520,321.50. Following the completion of the sale, the senior vice president now directly owns 29,669 shares in the company, valued at approximately $4,786,796.46. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Diego J. Barral sold 1,987 shares of the company’s stock in a transaction on Friday, August 2nd. The stock was sold at an average price of $157.59, for a total value of $313,131.33. The disclosure for this sale can be found here. Insiders sold a total of 15,609 shares of company stock valued at $2,497,443 over the last quarter. Company insiders own 1.14% of the company’s stock.

CLX has been the topic of several research analyst reports. Morgan Stanley reaffirmed an “underweight” rating and issued a $134.00 price objective (down previously from $144.00) on shares of Clorox in a research report on Monday, September 30th. Wells Fargo & Co reaffirmed a “hold” rating and issued a $150.00 price objective on shares of Clorox in a research report on Wednesday, October 2nd. Zacks Investment Research raised Clorox from a “sell” rating to a “hold” rating and set a $175.00 price objective on the stock in a research report on Monday, July 29th. Credit Suisse Group cut their price objective on Clorox from $172.00 to $168.00 and set an “outperform” rating on the stock in a research report on Thursday, October 3rd. Finally, Bank of America cut their price objective on Clorox from $165.00 to $160.00 and set a “neutral” rating on the stock in a research report on Thursday, October 3rd. Four investment analysts have rated the stock with a sell rating, eight have issued a hold rating and two have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $152.25.

Shares of CLX stock traded up $0.87 during mid-day trading on Thursday, hitting $150.68. The stock had a trading volume of 326,848 shares, compared to its average volume of 989,727. Clorox Co has a 12-month low of $143.58 and a 12-month high of $167.70. The firm has a market capitalization of $18.62 billion, a P/E ratio of 23.84, a price-to-earnings-growth ratio of 4.97 and a beta of 0.40. The firm’s 50-day moving average is $153.18 and its two-hundred day moving average is $154.76. The company has a debt-to-equity ratio of 4.09, a current ratio of 0.91 and a quick ratio of 0.55.

Clorox (NYSE:CLX) last issued its earnings results on Thursday, August 1st. The company reported $1.88 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.84 by $0.04. Clorox had a return on equity of 118.88% and a net margin of 13.20%. The business had revenue of $1.63 billion during the quarter, compared to analysts’ expectations of $1.69 billion. During the same period in the prior year, the business earned $1.66 EPS. The business’s revenue for the quarter was down 3.8% compared to the same quarter last year. Analysts expect that Clorox Co will post 6.18 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Wednesday, October 30th will be issued a $1.06 dividend. This represents a $4.24 annualized dividend and a dividend yield of 2.81%. The ex-dividend date of this dividend is Tuesday, October 29th. Clorox’s dividend payout ratio is 67.09%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Featured Story: How does inflation affect different investments?

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.